Biden’s Diagnosis Brings Prostate Cancer Into Focus—Expert Shares What Every Man Should Know
In the wake of former President Joe Biden's announcement that he has been diagnosed with an aggressive form of prostate cancer that has metastasized to his bones , the conversation around prostate health has gained renewed urgency.
To shed light on this critical issue, Radio Catskill's Patricio Robayo spoke with Dr. Sheldon L. Axelrod, a urologist with Optum Health and Clinical Assistant Professor at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell.
To shed light on this critical issue, Radio Catskill's Patricio Robayo spoke with Dr. Sheldon L. Axelrod, a urologist with Optum Health and Clinical Assistant Professor at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell.
Early Detection is Key
Dr. Axelrod emphasized the importance of early screening for prostate cancer. "For individuals at average risk, starting screening at age 50 is reasonable," he noted. However, for those with higher risk factors—such as African American men or those with a family history of prostate cancer—screening should begin earlier, around age 45, or even 40 in some cases.
Silent Progression
One of the challenges with prostate cancer is its often silent progression. "Typically, early-stage prostate cancer doesn't present symptoms," Dr. Axelrod explained. "Symptoms like bone pain or urinary difficulties usually indicate more advanced disease." This underscores the necessity of regular screenings, even in the absence of symptoms.
Diagnostic Tools
The primary screening tools for prostate cancer are the Prostate-Specific Antigen (PSA) blood test and the digital rectal exam. While an elevated PSA level doesn't definitively indicate cancer, it warrants further investigation. "If the PSA is elevated, we typically repeat the test and may conduct an MRI to assess the prostate's condition," Dr. Axelrod said. "Depending on the findings, a biopsy might be necessary."
Treatment Options
Treatment strategies for prostate cancer vary based on the disease's stage and aggressiveness. "For low-risk cases, active surveillance might be sufficient," Dr. Axelrod stated. "More aggressive cancers may require surgical removal of the prostate or radiation therapy." He also highlighted advancements in robotic-assisted surgeries, which have improved patient outcomes and recovery times.
Lifestyle and Prevention
While certain risk factors like age and genetics are non-modifiable, Dr. Axelrod advocated for a healthy lifestyle. "Regular exercise, a balanced diet, and maintaining a healthy weight can contribute to overall well-being and may help reduce cancer risk," he advised.
Dr. Axelrod's insights serve as a timely reminder of the importance of proactive health measures and regular screenings in the fight against prostate cancer.
